tiprankstipranks
Integrated BioPharma Inc (INBP)
OTHER OTC:INBP
US Market

Integrated BioPharma (INBP) Financial Statements

Compare
8 Followers

Integrated BioPharma Financial Overview

Integrated BioPharma's market cap is currently $9.86M. The company's EPS TTM is $0.03; its P/E ratio is 10.10; Integrated BioPharma is scheduled to report earnings on February 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total Revenue$ 50.32M$ 50.67M$ 56.25M$ 63.56M$ 52.77M
Gross Profit$ 3.88M$ 4.06M$ 6.55M$ 9.48M$ 6.73M
Operating Income$ 251.00K$ 120.00K$ 1.97M$ 5.78M$ 2.38M
EBITDA$ 1.47M$ 1.27M$ 3.56M$ 8.33M$ 4.26M
Net Income$ 112.00K$ -34.00K$ 3.84M$ 8.01M$ 4.11M
Balance Sheet
Cash & Short-Term Investments$ 1.68M$ 1.32M$ 331.00K$ 210.00K$ 402.00K
Total Assets$ 26.21M$ 25.43M$ 25.25M$ 25.44M$ 22.94M
Total Debt$ 1.80M$ 2.67M$ 2.06M$ 6.00M$ 11.13M
Net Debt$ 121.00K$ 1.36M$ 1.72M$ 5.79M$ 10.73M
Total Liabilities$ 6.97M$ 6.57M$ 6.67M$ 11.11M$ 16.88M
Stockholders' Equity$ 19.24M$ 18.86M$ 18.57M$ 14.33M$ 6.07M
Cash Flow
Free Cash Flow$ 390.00K$ 1.12M$ 3.60M$ 2.75M$ 1.13M
Operating Cash Flow$ 943.00K$ 1.23M$ 4.09M$ 3.05M$ 1.34M
Investing Cash Flow$ -553.00K$ -111.00K$ -465.00K$ -199.00K$ -110.00K
Financing Cash Flow$ -29.00K$ -136.00K$ -3.50M$ -3.04M$ -1.30M
Currency in USD

Integrated BioPharma Earnings and Revenue History

Integrated BioPharma Debt to Assets

Integrated BioPharma Cash Flow

Integrated BioPharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis